Related Experiment Video
Updated: Sep 25, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Drug-induced aseptic meningitis
Eustachio Nettis1, Gianfranco Calogiuri, Maria Cristina Colanardi
1Department of Medical Clinic, Immunology and Infectious Diseases, Division of Allergy and Clinical Immunology, University of Bari, Italy. e.nettis@allergy.uniba.it
Abstract:
Aseptic meningitis is a rare but well-recognized complication of drug therapy. The clinical presentation of drug-induced aseptic meningitis (DIAM) is distinct. Symptoms typically include fever, neck stiffness, headache, confusion, nausea and vomiting. The major categories of causative agents are non-steroidal anti-inflammatory drugs, antimicrobials and also intravenous immunoglobulins, monoclonal antibodies and vaccines. These drugs most commonly implicated as causes of aseptic meningitis act more likely through an immunological mechanisms. However, the exact pathogenetic mechanism of DIAM is still unknown. The diagnosis of drug-induced aseptic meningitis is difficult and infectious etiologies must be excluded. In some cases the diagnosis has been confirmed by rechallenging the patient with the suspected agent. In this case, informed written consent is necessary and rechallenge must be medically supervised both to document the response and to offer medical care and advice, if required. The outcome of DIAM is generally good, usually without long term sequelae.
Insights
Drug-induced aseptic meningitis (DIAM) is a rare complication of certain medications, presenting with distinct symptoms like fever and headache. While the exact cause is unknown, DIAM typically resolves without long-term effects.
Area of Science:
- Neurology
- Pharmacology
- Immunology
Background:
- Aseptic meningitis is an infrequent but recognized adverse effect of various drug therapies.
- Drug-induced aseptic meningitis (DIAM) presents with a characteristic set of symptoms including fever, neck stiffness, headache, confusion, nausea, and vomiting.
Purpose of the Study:
- To review the clinical presentation, causative agents, diagnostic challenges, and outcomes of drug-induced aseptic meningitis.
- To highlight the importance of considering DIAM in differential diagnoses and the potential role of immunological mechanisms.
Main Methods:
- Review of literature on drug-induced aseptic meningitis.
- Analysis of clinical presentations and implicated drug categories (NSAIDs, antimicrobials, IVIg, monoclonal antibodies, vaccines).
- Discussion of diagnostic approaches, including exclusion of infectious causes and supervised rechallenge.
Main Results:
- Commonly implicated drugs often trigger DIAM through immunological pathways, though the precise pathogenesis remains unclear.
- Diagnosis is challenging, requiring exclusion of infectious meningitis and potentially confirmed by medically supervised rechallenge.
- The prognosis for DIAM is generally favorable, with most patients experiencing a full recovery without lasting sequelae.
Conclusions:
- Drug-induced aseptic meningitis is a distinct clinical entity with a generally good prognosis.
- Awareness of causative agents and diagnostic criteria is crucial for timely management.
- Further research into the pathogenetic mechanisms of DIAM is warranted.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Encephalitis l: Introduction

